CoreWeave, Inc. (CRWV) Insider Transactions

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F2 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025.

F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.18 to $95.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this filing.

F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.18 to $96.15, inclusive.

F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.26 to $97.25, inclusive.

F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.26 to $98.25, inclusive.

F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.26 to $99.25, inclusive.

F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.26 to $99.765, inclusive.

F10 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

F11 The reported securities are directly held by Omnadora Capital LLC ("Omnadora"). The reporting person is the sole manager of Omnadora's manager, Omnadora Management LLC. In such capacity, the reporting person may be deemed to beneficially own securities directly held by Omnadora. The reporting person disclaims beneficial ownership for purposes of Section 16 of the Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein.

F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.18 to $95.07, inclusive.

F13 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

F14 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

F15 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

F16 The reported securities are directly held by the PMI 2024 F&F GRAT (the "PMI GRAT"). The reporting person is the sole beneficiary of the PMI GRAT and his spouse is trustee.

F17 The reported securities are directly held by the Intrator Family GST-Exempt Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.

F18 The reported securities are directly held by the Intrator Family Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.

F19 The reported securities are directly held by the reporting person's spouse.

References: F3, F6

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F2 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025.

F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.18 to $95.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this filing.

F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.18 to $96.15, inclusive.

F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.26 to $97.25, inclusive.

F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.26 to $98.25, inclusive.

F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.26 to $99.25, inclusive.

F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.26 to $99.765, inclusive.

F10 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

F11 The reported securities are directly held by Omnadora Capital LLC ("Omnadora"). The reporting person is the sole manager of Omnadora's manager, Omnadora Management LLC. In such capacity, the reporting person may be deemed to beneficially own securities directly held by Omnadora. The reporting person disclaims beneficial ownership for purposes of Section 16 of the Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein.

F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.18 to $95.07, inclusive.

F13 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

F14 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

F15 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

F16 The reported securities are directly held by the PMI 2024 F&F GRAT (the "PMI GRAT"). The reporting person is the sole beneficiary of the PMI GRAT and his spouse is trustee.

F17 The reported securities are directly held by the Intrator Family GST-Exempt Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.

F18 The reported securities are directly held by the Intrator Family Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.

F19 The reported securities are directly held by the reporting person's spouse.

References: F3, F5

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F2 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025.

F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.18 to $95.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this filing.

F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.18 to $96.15, inclusive.

F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.26 to $97.25, inclusive.

F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.26 to $98.25, inclusive.

F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.26 to $99.25, inclusive.

F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.26 to $99.765, inclusive.

F10 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

F11 The reported securities are directly held by Omnadora Capital LLC ("Omnadora"). The reporting person is the sole manager of Omnadora's manager, Omnadora Management LLC. In such capacity, the reporting person may be deemed to beneficially own securities directly held by Omnadora. The reporting person disclaims beneficial ownership for purposes of Section 16 of the Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein.

F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.18 to $95.07, inclusive.

F13 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

F14 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

F15 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

F16 The reported securities are directly held by the PMI 2024 F&F GRAT (the "PMI GRAT"). The reporting person is the sole beneficiary of the PMI GRAT and his spouse is trustee.

F17 The reported securities are directly held by the Intrator Family GST-Exempt Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.

F18 The reported securities are directly held by the Intrator Family Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.

F19 The reported securities are directly held by the reporting person's spouse.

References: F3, F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F2 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025.

F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.18 to $95.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this filing.

F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.18 to $96.15, inclusive.

F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.26 to $97.25, inclusive.

F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.26 to $98.25, inclusive.

F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.26 to $99.25, inclusive.

F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.26 to $99.765, inclusive.

F10 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

F11 The reported securities are directly held by Omnadora Capital LLC ("Omnadora"). The reporting person is the sole manager of Omnadora's manager, Omnadora Management LLC. In such capacity, the reporting person may be deemed to beneficially own securities directly held by Omnadora. The reporting person disclaims beneficial ownership for purposes of Section 16 of the Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein.

F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.18 to $95.07, inclusive.

F13 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

F14 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

F15 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

F16 The reported securities are directly held by the PMI 2024 F&F GRAT (the "PMI GRAT"). The reporting person is the sole beneficiary of the PMI GRAT and his spouse is trustee.

F17 The reported securities are directly held by the Intrator Family GST-Exempt Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.

F18 The reported securities are directly held by the Intrator Family Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.

F19 The reported securities are directly held by the reporting person's spouse.

References: F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F2 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025.

F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.18 to $95.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this filing.

F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.18 to $96.15, inclusive.

F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.26 to $97.25, inclusive.

F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.26 to $98.25, inclusive.

F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.26 to $99.25, inclusive.

F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.26 to $99.765, inclusive.

F10 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

F11 The reported securities are directly held by Omnadora Capital LLC ("Omnadora"). The reporting person is the sole manager of Omnadora's manager, Omnadora Management LLC. In such capacity, the reporting person may be deemed to beneficially own securities directly held by Omnadora. The reporting person disclaims beneficial ownership for purposes of Section 16 of the Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein.

F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.18 to $95.07, inclusive.

F13 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

F14 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

F15 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

F16 The reported securities are directly held by the PMI 2024 F&F GRAT (the "PMI GRAT"). The reporting person is the sole beneficiary of the PMI GRAT and his spouse is trustee.

F17 The reported securities are directly held by the Intrator Family GST-Exempt Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.

F18 The reported securities are directly held by the Intrator Family Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.

F19 The reported securities are directly held by the reporting person's spouse.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F2 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025.

F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.18 to $95.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this filing.

F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.18 to $96.15, inclusive.

F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.26 to $97.25, inclusive.

F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.26 to $98.25, inclusive.

F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.26 to $99.25, inclusive.

F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.26 to $99.765, inclusive.

F10 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

F11 The reported securities are directly held by Omnadora Capital LLC ("Omnadora"). The reporting person is the sole manager of Omnadora's manager, Omnadora Management LLC. In such capacity, the reporting person may be deemed to beneficially own securities directly held by Omnadora. The reporting person disclaims beneficial ownership for purposes of Section 16 of the Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein.

F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.18 to $95.07, inclusive.

F13 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

F14 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

F15 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

F16 The reported securities are directly held by the PMI 2024 F&F GRAT (the "PMI GRAT"). The reporting person is the sole beneficiary of the PMI GRAT and his spouse is trustee.

F17 The reported securities are directly held by the Intrator Family GST-Exempt Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.

F18 The reported securities are directly held by the Intrator Family Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.

F19 The reported securities are directly held by the reporting person's spouse.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F2 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F3 The award vested as to 1/4 of the total award on March 31, 2026, and vests thereafter as to 1/16 of the total award on the last calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date.

F4 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

References: F1, F3, F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F2 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F3 The award vested as to 1/4 of the total award on March 31, 2026, and vests thereafter as to 1/16 of the total award on the last calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date.

F4 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

References: F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F2 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F3 The award vested as to 1/4 of the total award on March 31, 2026, and vests thereafter as to 1/16 of the total award on the last calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date.

F4 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F2 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F3 The award shall vest as to 1/4 of the total award on March 31, 2026, and thereafter shall vest as to 1/16 of the total award on the last calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date.

F4 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

References: F1, F3, F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F2 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F3 The award shall vest as to 1/4 of the total award on March 31, 2026, and thereafter shall vest as to 1/16 of the total award on the last calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date.

F4 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

References: F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F2 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F3 The award shall vest as to 1/4 of the total award on March 31, 2026, and thereafter shall vest as to 1/16 of the total award on the last calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date.

F4 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F2 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F3 The reported securities are directly held by the Yellowstone 2025 GRAT, of which the reporting person's spouse is the beneficiary and for which the reporting person serves as trustee.

F4 The reported securities are directly held by the Yosemite 2025 GRAT, of which the reporting person is the sole trustee and beneficiary.

F5 The award was granted subject to a performance-based vesting condition which was satisfied in connection with the Issuer's initial public offering, as well as a service-based vesting schedule. The award shall vest as to 1/4 of the total award on March 31, 2026, and thereafter shall vest as to 1/16 of the total award on the last calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date.

F6 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

References: F1, F5, F6

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F2 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F3 The reported securities are directly held by the Yellowstone 2025 GRAT, of which the reporting person's spouse is the beneficiary and for which the reporting person serves as trustee.

F4 The reported securities are directly held by the Yosemite 2025 GRAT, of which the reporting person is the sole trustee and beneficiary.

F5 The award was granted subject to a performance-based vesting condition which was satisfied in connection with the Issuer's initial public offering, as well as a service-based vesting schedule. The award shall vest as to 1/4 of the total award on March 31, 2026, and thereafter shall vest as to 1/16 of the total award on the last calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date.

F6 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

References: F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F2 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F3 The reported securities are directly held by the Yellowstone 2025 GRAT, of which the reporting person's spouse is the beneficiary and for which the reporting person serves as trustee.

F4 The reported securities are directly held by the Yosemite 2025 GRAT, of which the reporting person is the sole trustee and beneficiary.

F5 The award was granted subject to a performance-based vesting condition which was satisfied in connection with the Issuer's initial public offering, as well as a service-based vesting schedule. The award shall vest as to 1/4 of the total award on March 31, 2026, and thereafter shall vest as to 1/16 of the total award on the last calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date.

F6 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive.

F3 The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.

F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive.

F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive.

F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive.

F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive.

F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive.

F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive.

F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive.

F11 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F12 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F13 The reported securities are directly held of record by the reporting person's child.

F14 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

F15 The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.

F16 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary.

F17 The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.

F18 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee.

F19 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

F20 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

F21 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person are continued on this Part 3.

References: F11, F21, F20

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive.

F3 The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.

F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive.

F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive.

F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive.

F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive.

F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive.

F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive.

F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive.

F11 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F12 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F13 The reported securities are directly held of record by the reporting person's child.

F14 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

F15 The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.

F16 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary.

F17 The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.

F18 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee.

F19 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

F20 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

F21 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person are continued on this Part 3.

References: F11, F19, F20

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive.

F3 The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.

F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive.

F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive.

F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive.

F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive.

F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive.

F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive.

F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive.

F11 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F12 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F13 The reported securities are directly held of record by the reporting person's child.

F14 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

F15 The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.

F16 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary.

F17 The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.

F18 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee.

F19 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

F20 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

F21 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person are continued on this Part 3.

References: F12

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive.

F3 The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.

F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive.

F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive.

F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive.

F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive.

F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive.

F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive.

F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive.

F11 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F12 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F13 The reported securities are directly held of record by the reporting person's child.

F14 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

F15 The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.

F16 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary.

F17 The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.

F18 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee.

F19 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

F20 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

F21 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person are continued on this Part 3.

References: F11

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive.

F3 The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.

F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive.

F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive.

F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive.

F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive.

F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive.

F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive.

F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive.

F11 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F12 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F13 The reported securities are directly held of record by the reporting person's child.

F14 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

F15 The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.

F16 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary.

F17 The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.

F18 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee.

F19 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

F20 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

F21 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person are continued on this Part 3.

References: F11

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive.

F3 The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.

F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive.

F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive.

F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive.

F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive.

F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive.

F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive.

F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive.

F11 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F12 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F13 The reported securities are directly held of record by the reporting person's child.

F14 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

F15 The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.

F16 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary.

F17 The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.

F18 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee.

F19 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

F20 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

F21 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person are continued on this Part 3.

References: F1, F3

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive.

F3 The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.

F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive.

F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive.

F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive.

F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive.

F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive.

F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive.

F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive.

F11 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F12 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F13 The reported securities are directly held of record by the reporting person's child.

F14 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

F15 The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.

F16 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary.

F17 The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.

F18 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee.

F19 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

F20 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

F21 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person are continued on this Part 3.

References: F1, F10, F3

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive.

F3 The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.

F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive.

F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive.

F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive.

F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive.

F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive.

F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive.

F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive.

F11 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F12 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F13 The reported securities are directly held of record by the reporting person's child.

F14 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

F15 The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.

F16 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary.

F17 The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.

F18 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee.

F19 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

F20 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

F21 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person are continued on this Part 3.

References: F1, F9, F3

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive.

F3 The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.

F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive.

F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive.

F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive.

F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive.

F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive.

F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive.

F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive.

F11 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F12 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F13 The reported securities are directly held of record by the reporting person's child.

F14 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

F15 The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.

F16 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary.

F17 The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.

F18 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee.

F19 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

F20 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

F21 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person are continued on this Part 3.

References: F1, F8, F3

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive.

F3 The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.

F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive.

F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive.

F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive.

F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive.

F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive.

F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive.

F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive.

F11 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F12 The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units.

F13 The reported securities are directly held of record by the reporting person's child.

F14 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

F15 The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.

F16 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary.

F17 The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.

F18 The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee.

F19 The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors.

F20 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

F21 The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.

This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person are continued on this Part 3.

References: F1, F7, F3